STAT5 A/B Antikörper (pTyr694, pTyr699, Tyr699)
(1 reference)-
- Target Alle STAT5 A/B Produkte
- STAT5 A/B
-
Bindungsspezifität
- pTyr694, pTyr699, Tyr699
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser STAT5 A/B Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Dot Blot (DB)
- Aufreinigung
- Affinity Purified
- Immunogen
- This STAT5A/B pTyr694/Tyr699 antibody was raised against a peptide containing pTyr694 of human STAT5A. Human STAT5B shares the identical sequence surrounding Tyr699.
- Isotyp
- IgG
-
anti-STAT5 A/B (STAT5 A/B) (pSer725), (pSer730) antibody
STAT5 A/B Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-STAT5 A/B (STAT5 A/B) (pTyr694) antibodySTAT5 A/B Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-STAT5 A/B (STAT5 A/B) (AA 696-745), (pSer726) antibodySTAT5 A/B Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-STAT5 A/B (STAT5 A/B) (C-Term) antibodySTAT5 A/B Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-STAT5 A/B (STAT5 A/B) (pSer726), (pSer731), (Ser731) antibodySTAT5 A/B Reaktivität: Human WB, DB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
-
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Antibodies in solution can be stored at -20 °C for 2 years.
- Haltbarkeit
- 6 months
-
-
: "Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways." in: Oncotarget, Vol. 8, Issue 13, pp. 21579-21598, (2017) (PubMed).
-
: "Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways." in: Oncotarget, Vol. 8, Issue 13, pp. 21579-21598, (2017) (PubMed).
-
- Target
- STAT5 A/B
- Andere Bezeichnung
- STAT5A/B (STAT5 A/B Produkte)
- Molekulargewicht
- 92 kDa
- Gen-ID
- 6776
-
